The pulse of inflammation: Heart rate variability, the cholinergic anti-inflammatory pathway and implications for therapy

Journal of Internal Medicine

Volumn 269, Issue 1, 2011, Pages 45-53

  Huston, J M ^a   Tracey, K J ^b  

^a STONY BROOK UNIVERSITY MEDICAL CENTER   (United States)

^b FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH   (United States)

Author keywords

Heart rate variability; Inflammation; Neuro immunology; Therapeutics; Vagus nerve stimulation

Indexed keywords

ACETYLCHOLINE; CYTOKINE; INTERLEUKIN 1; INTERLEUKIN 6; NICOTINIC ALPHA7 ACETYLCHOLINE RECEPTOR; NICOTINIC RECEPTOR; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG;

ACETYLCHOLINE RELEASE; ACTION POTENTIAL; CHOLINERGIC SYSTEM; CONFERENCE PAPER; CYTOKINE PRODUCTION; GENE EXPRESSION; HEART RATE VARIABILITY; HUMAN; IMMUNOREGULATION; INFLAMMATION; INFLAMMATORY BREAST CANCER; NONHUMAN; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; TRANSLATION REGULATION; VAGUS NERVE;

ACETYLCHOLINE; ANTI-INFLAMMATORY AGENTS; CYTOKINES; HEART RATE; HUMANS; INFLAMMATION; NEUROIMMUNOMODULATION; SIGNAL TRANSDUCTION; VAGUS NERVE;

EID: 78650218512     PISSN: 09546820     EISSN: 13652796     Source Type: Journal    
DOI: 10.1111/j.1365-2796.2010.02321.x     Document Type: Conference Paper

References (69)

1. Lotze MT, Tracey KJ. High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal. Nat Rev Immunol 2005; 5: 331-42.
2. Yang H, Hreggvidsdottir HS, Palmblad K et al. A Critical Cysteine is Required for HMGB1 Binding to TLR4 and Activation of Macrophage Cytokine Release. Proc Natl Acad Sci USA 2010; 26: 11942-7.
3. Medzhitov R. Inflammation 2010: new adventures of an old flame. Cell 2010; 140: 771-6.
4. Borovikova LV, Ivanova S, Nardi D et al. Role of vagus nerve signaling in CNI-1493-mediated suppression of acute inflammation. Auton Neurosci 2000; 85: 141-7.
5. Borovikova LV, Ivanova S, Zhang M et al. Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature 2000; 405: 458-62.
6. Tracey KJ. The inflammatory reflex. Nature 2002; 420: 853-9.
7. Huston JM, Ochani M, Rosas-Ballina M et al. Splenectomy inactivates the cholinergic antiinflammatory pathway during lethal endotoxemia and polymicrobial sepsis. J Exp Med 2006; 203: 1623-8.
8. Wang H, Yu M, Ochani M et al. Nicotinic acetylcholine receptor alpha7 subunit is an essential regulator of inflammation. Nature 2003; 421: 384-8.
9. Bernik TR, Friedman SG, Ochani M et al. Pharmacological stimulation of the cholinergic antiinflammatory pathway. J Exp Med 2002; 195: 781-8.
10. Bernik TR, Friedman SG, Ochani M et al. Cholinergic antiinflammatory pathway inhibition of tumor necrosis factor during ischemia reperfusion. J Vasc Surg 2002; 36: 1231-6.
11. van Westerloo DJ, Giebelen IA, Florquin S et al. The vagus nerve and nicotinic receptors modulate experimental pancreatitis severity in mice. Gastroenterology 2006; 130: 1822-30.
12. van Westerloo DJ, Giebelen IA, Florquin S et al. The cholinergic anti-inflammatory pathway regulates the host response during septic peritonitis. J Infect Dis 2005; 191: 2138-48.
13. Huston JM, Gallowitsch-Puerta M, Ochani M et al. Transcutaneous vagus nerve stimulation reduces serum high mobility group box 1 levels and improves survival in murine sepsis. Crit Care Med 2007; 35: 2762-8.
14. Yeboah MM, Xue X, Duan B et al. Cholinergic agonists attenuate renal ischemia-reperfusion injury in rats. Kidney Int 2008; 74: 62-9.
15. van Maanen MA, Lebre MC, van der PT et al. Stimulation of nicotinic acetylcholine receptors attenuates collagen-induced arthritis in mice. Arthritis Rheum 2009; 60: 114-22.
16. Mioni C, Bazzani C, Giuliani D et al. Activation of an efferent cholinergic pathway produces strong protection against myocardial ischemia/reperfusion injury in rats. Crit Care Med 2005; 33: 2621-8.
17. Guarini S, Cainazzo MM, Giuliani D et al. Adrenocorticotropin reverses hemorrhagic shock in anesthetized rats through the rapid activation of a vagal anti-inflammatory pathway. Cardiovasc Res 2004; 63: 357-65.
18. Guarini S, Altavilla D, Cainazzo MM et al. Efferent vagal fibre stimulation blunts nuclear factor-kappaB activation and protects against hypovolemic hemorrhagic shock. Circulation 2003; 107: 1189-94.
19. Ottani A, Giuliani D, Galantucci M et al. Melanocortins counteract inflammatory and apoptotic responses to prolonged myocardial ischemia/reperfusion through a vagus nerve-mediated mechanism. Eur J Pharmacol 2010; 637: 124-30.
20. Li J, Xie H, Wen T, Liu H, Zhu W, Chen X. Expression of high mobility group box chromosomal protein 1 and its modulating effects on downstream cytokines in systemic lupus erythematosus. J Rheumatol 2010; 37: 766-75.
21. Tracey KJ. Understanding immunity requires more than immunology. Nat Immunol 2010; 11: 561-4.
22. Parrish WR, Rosas-Ballina M, Gallowitsch-Puerta M et al. Modulation of TNF Release by Choline Requires Alpha7 Subunit Nicotinic Acetylcholine Receptor-Mediated Signaling. Mol Med 2008; 14: 567-74.
23. de Jonge WJ, van der Zanden EP, The FO et al. Stimulation of the vagus nerve attenuates macrophage activation by activating the Jak2-STAT3 signaling pathway. Nat Immunol 2005; 6: 844-51.
24. Wang H, Liao H, Ochani M et al. Cholinergic agonists inhibit HMGB1 release and improve survival in experimental sepsis. Nat Med 2004; 10: 1216-21.
25. Huston JM, Wang H, Ochani M et al. Splenectomy protects against sepsis lethality and reduces serum HMGB1 levels. J Immunol 2008; 181: 3535-9.
26. Rosas-Ballina M, Tracey KJ. The neurology of the immune system: neural reflexes regulate immunity. Neuron 2009; 64: 28-32.
27. Rosas-Ballina M, Ochani M, Parrish WR et al. Splenic nerve is required for cholinergic antiinflammatory pathway control of TNF in endotoxemia. Proc Natl Acad Sci USA 2008; 105: 11008-13.
28. Huston JM, Rosas-Ballina M, Xue X et al. Cholinergic neural signals to the spleen down-regulate leukocyte trafficking via CD11b. J Immunol 2009; 183: 552-9.
29. Saeed RW, Varma S, Peng-Nemeroff T et al. Cholinergic stimulation blocks endothelial cell activation and leukocyte recruitment during inflammation. J Exp Med 2005; 201: 1113-23.
30. Brigden ML, Pattullo AL. Prevention and management of overwhelming postsplenectomy infection--an update. Crit Care Med 1999; 27: 836-42.
31. Tracey KJ. Suppression of TNF and other proinflammatory cytokines by the tetravalent guanylhydrazone CNI-1493. Prog Clin Biol Res 1998; 397: 335-43.
32. Pavlov VA, Parrish WR, Rosas-Ballina M et al. Brain acetylcholinesterase activity controls systemic cytokine levels through the cholinergic anti-inflammatory pathway. Brain Behav Immun 2009; 23: 41-5.
33. Pavlov VA, Ochani M, Gallowitsch-Puerta M et al. Central muscarinic cholinergic regulation of the systemic inflammatory response during endotoxemia. Proc Natl Acad Sci USA 2006; 103: 5219-23.
34. Li Y, Wu X, Zhu J, Yan J, Owyang C. Hypothalamic regulation of pancreatic secretion is mediated by central cholinergic pathways in the rat. J Physiol 2003; 552: 571-87.
35. Shimazu T, Matsushita H, Ishikawa K. Cholinergic stimulation of the rat hypothalamus: effects of liver glycogen synthesis. Science 1976; 194: 535-6.
36. Sloan RP, McCreath H, Tracey KJ, Sidney S, Liu K, Seeman T. RR interval variability is inversely related to inflammatory markers: the CARDIA study. Mol Med 2007; 13: 178-84.
37. Heart rate variability: standards of measurement, physiological interpretation and clinical use. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Circulation 1996; 93: 1043-65.
38. Gaziano EP, Freeman DW. Analysis of heart rate patterns preceding fetal death. Obstet Gynecol 1977; 50: 578-82.
39. Sampson MB, Mudaliar NA, Lele AS. Fetal heart rate variability as an indicator of fetal status. Postgrad Med 1980; 67: 207-10, 213-15.
40. Lauersen NH, Wilson KH, Bilek A, Rao VS, Kurkulos M. A new modality in nonstress testing: evaluation of beat-to-beat fetal heart rate variability. Am J Obstet Gynecol 1981; 141: 521-6.
41. Kleiger RE, Miller JP, Bigger JT Jr, Moss AJ. Decreased heart rate variability and its association with increased mortality after acute myocardial infarction. Am J Cardiol 1987; 59: 256-62.
42. La Rovere MT, Bigger JT Jr, Marcus FI, Mortara A, Schwartz PJ. Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction. ATRAMI (Autonomic Tone and Reflexes After Myocardial Infarction) Investigators. Lancet 1998; 351: 478-84.
43. Schwartz PJ, La Rovere MT, Vanoli E. Autonomic nervous system and sudden cardiac death. Experimental basis and clinical observations for post-myocardial infarction risk stratification. Circulation 1992; 85: I77-91.
44. Garrard CS, Kontoyannis DA, Piepoli M. Spectral analysis of heart rate variability in the sepsis syndrome. Clin Auton Res 1993; 3: 5-13.
45. Schmidt H, Muller-Werdan U, Hoffmann T et al. Autonomic dysfunction predicts mortality in patients with multiple organ dysfunction syndrome of different age groups. Crit Care Med 2005; 33: 1994-2002.
46. Aydemir M, Yazisiz V, Basarici I et al. Cardiac autonomic profile in rheumatoid arthritis and systemic lupus erythematosus. Lupus 2010; 19: 255-61.
47. Stojanovich L, Milovanovich B, de Luka SR et al. Cardiovascular autonomic dysfunction in systemic lupus, rheumatoid arthritis, primary Sjogren syndrome and other autoimmune diseases. Lupus 2007; 16: 181-5.
48. Sharma P, Makharia GK, Ahuja V, Dwivedi SN, Deepak KK. Autonomic dysfunctions in patients with inflammatory bowel disease in clinical remission. Dig Dis Sci 2009; 54: 853-61.
49. Lindgren S, Stewenius J, Sjolund K, Lilja B, Sundkvist G. Autonomic vagal nerve dysfunction in patients with ulcerative colitis. Scand J Gastroenterol 1993; 28: 638-42.
50. Bruchfeld A, Goldstein RS, Chavan S et al. Whole blood cytokine attenuation by cholinergic agonists ex vivo and relationship to vagus nerve activity in rheumatoid arthritis. J Intern Med 2010; 268: 94-101.
51. Goldstein RS, Bruchfeld A, Yang L et al. Cholinergic anti-inflammatory pathway activity and High Mobility Group Box-1 (HMGB1) serum levels in patients with rheumatoid arthritis. Mol Med 2007; 13: 210-5.
52. Jan BU, Coyle SM, Macor MA, Reddell M, Calvano SE, Lowry SF. Relationship of basal heart rate variability to in vivo cytokine responses after endotoxin exposure. Shock 2010; 33: 363-8.
53. Hoeger S, Bergstraesser C, Selhorst J et al. Modulation of brain dead induced inflammation by vagus nerve stimulation. Am J Transplant 2010; 10: 477-89.
54. Dantzer R, O'Connor JC, Freund GG, Johnson RW, Kelley KW. From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci 2008; 9: 46-56.
55. Raison CL, Capuron L, Miller AH. Cytokines sing the blues: inflammation and the pathogenesis of depression. Trends Immunol 2006; 27: 24-31.
56. Miller AH, Maletic V, Raison CL. Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression. Biol Psychiatry 2009; 65: 732-41.
57. Kemp AH, Quintana DS, Gray MA, Felmingham KL, Brown K, Gatt JM. Impact of depression and antidepressant treatment on heart rate variability: a review and meta-analysis. Biol Psychiatry 2010; 67: 1067-74.
58. Bajbouj M, Merkl A, Schlaepfer TE et al. Two-year outcome of vagus nerve stimulation in treatment-resistant depression. J Clin Psychopharmacol 2010; 30: 273-81.
59. Rush AJ, Sackeim HA, Marangell LB et al. Effects of 12 months of vagus nerve stimulation in treatment-resistant depression: a naturalistic study. Biol Psychiatry 2005; 58: 355-63.
60. Marangell LB, Rush AJ, George MS et al. Vagus nerve stimulation (VNS) for major depressive episodes: one year outcomes. Biol Psychiatry 2002; 51: 280-7.
61. Dowlati Y, Herrmann N, Swardfager W et al. A meta-analysis of cytokines in major depression. Biol Psychiatry 2010; 67: 446-57.
62. Lampert R, Bremner JD, Su S et al. Decreased heart rate variability is associated with higher levels of inflammation in middle-aged men. Am Heart J 2008; 156: 759.e1-7.
63. Haensel A, Mills PJ, Nelesen RA, Ziegler MG, Dimsdale JE. The relationship between heart rate variability and inflammatory markers in cardiovascular diseases. Psychoneuroendocrinology 2008; 33: 1305-12.
64. Carney RM, Freedland KE, Stein PK et al. Heart rate variability and markers of inflammation and coagulation in depressed patients with coronary heart disease. J Psychosom Res 2007; 62: 463-7.
65. Janszky I, Ericson M, Lekander M et al. Inflammatory markers and heart rate variability in women with coronary heart disease. J Intern Med 2004; 256: 421-8.
66. Frasure-Smith N, Lesperance F, Irwin MR, Talajic M, Pollock BG. The relationships among heart rate variability, inflammatory markers and depression in coronary heart disease patients. Brain Behav Immun 2009; 23: 1140-7.
67. Soares-Miranda L, Negrao CE, Antunes-Correa LM et al. High levels of C-reactive protein are associated with reduced vagal modulation and low physical activity in young adults. Scand J Med Sci Sports 2010; July 6. [Epub ahead of Print].
68. Sloan RP, Shapiro PA, Demeersman RE et al. Aerobic exercise attenuates inducible TNF production in humans. J Appl Physiol 2007; 103: 1007-11.
69. Marsland AL, Gianaros PJ, Prather AA, Jennings JR, Neumann SA, Manuck SB. Stimulated production of proinflammatory cytokines covaries inversely with heart rate variability. Psychosom Med 2007; 69: 709-16.